Pfizer PFE

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. THAILAND PRESS- Pfizer expects pharma recovery in 2015- Bangkok Post

      Headlines

      Mon, 22 Dec 2014

      New York-based Pfizer Inc expects solid growth in all sectors of Thailand's pharmaceutical ..... this year, the Bangkok Post reported, citing Christian Malherbe, Pfizer 's country head for Thailand and Indochina.

    2. AstraZeneca CEO says new Pfizer bid unlikely-Swedish daily DI

      Headlines

      Sat, 20 Dec 2014

      STOCKHOLM, Dec 20 (Reuters) - U.S. Pfizer is unlikely to come back with a fresh bid for AstraZeneca, the Anglo-Swedish pharmaceuticals group's top executive was quoted as saying by Swedish business...

    3. FDA warns Pfizer's antipsychotic could cause fatal skin reaction

      Headlines

      Thu, 11 Dec 2014

      Dec 11 (Reuters) - Pfizer Inc's antipsychotic Geodon and generic versions of the drug can trigger a potentially fatal skin reaction, the U.S. Food and Drug Administration warned on Thursday.

    4. Pfizer bets on gene therapy as technology comes of age

      Headlines

      Mon, 8 Dec 2014

      LONDON, Dec 8 (Reuters) - Pfizer Inc is moving into the gene therapy space in the latest sign that the technology for fixing faulty genes may finally be ready for prime time, following earlier setbacks.

    5. Breakthrough Ideas

      Headlines

      Thu, 4 Dec 2014

      been chemotherapy, a dose of Taxol or Alimta. That could end up being replaced by these new agents. In kidney cancer, Pfizer ’s Sutent therapy could be displaced. While investors have been excited about the possibilities of the new treatment

    6. UPDATE 3-AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer

      Headlines

      Tue, 18 Nov 2014

      * Investor day comes 8 days before Pfizer can resume pursuit

    7. BRIEF-AstraZeneca CEO says "hard to comment" on whether Pfizer will return

      Headlines

      Tue, 18 Nov 2014

      Nov 18 (Reuters) - AstraZeneca executives, speaking to reporters: * CEO says hard to comment on read-across from Pfizer /Merck cancer

    8. AstraZeneca trumpets progress in cancer, other drugs

      Headlines

      Tue, 18 Nov 2014

      LONDON, Nov 18 (Reuters) - AstraZeneca, determined to show it has a strong independent future after seeing off a $118 billion bid from Pfizer in May, said it had made good progress in developing a pipeline of new drugs.

    9. Mayne Pharma First to File with Generic Antiarrhythmic, Pfizer Skips a Beat

      Commentary

      Mon, 17 Nov 2014

      Pfizer Inc. has filed suit against Mayne Pharma ..... Drug Administration, or FDA--one that Pfizer alleges is infringing the patent for its ..... partner. Reported sales in the U.S. of Pfizer ’s Tikosyn for the 12 months ended September

    10. Pfizer dampens Astra bid hopes with German Merck cancer deal

      Headlines

      Mon, 17 Nov 2014

      FRANKFURT/LONDON (Reuters) - Pfizer dampened investors' expectations of a renewed bid for AstraZeneca on Monday by signing a major cancer drug deal with Germany's Merck KGaA , reducing the U.S. firm's need for Astra's products.

    « Prev12345Next »
    Content Partners